INCR
InterCure Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$5.42
+3.04%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.62x
- Price / sales
- 0.91x
- Price / cash flow
- 7.81x
Enterprise value
- Enterprise value
- $126.5M
- EV / sales
- 1.41x
- EV / EBITDA
- -6.89x
- EV / EBIT
- -13.99x
- Market cap
- $81.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025